StockNews.com Begins Coverage on Veradigm (NASDAQ:MDRX)

StockNews.com initiated coverage on shares of Veradigm (NASDAQ:MDRXFree Report) in a research note released on Sunday. The brokerage issued a hold rating on the software maker’s stock.

Separately, TD Cowen decreased their target price on shares of Veradigm from $26.00 to $15.00 and set a buy rating for the company in a research note on Tuesday, May 28th. Four equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of Hold and a consensus price target of $12.00.

Get Our Latest Research Report on MDRX

Veradigm Price Performance

Shares of MDRX stock opened at $9.81 on Friday. Veradigm has a 52-week low of $5.01 and a 52-week high of $14.09. The business has a 50-day simple moving average of $9.66 and a 200-day simple moving average of $8.90.

Institutional Investors Weigh In On Veradigm

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Innealta Capital LLC acquired a new position in shares of Veradigm during the 2nd quarter worth approximately $38,000. TFO Wealth Partners LLC boosted its stake in Veradigm by 105,280.0% during the fourth quarter. TFO Wealth Partners LLC now owns 5,269 shares of the software maker’s stock worth $52,000 after buying an additional 5,264 shares during the last quarter. Meadow Creek Wealth Advisors LLC acquired a new stake in shares of Veradigm in the 1st quarter worth $83,000. Forest Hill Capital LLC purchased a new position in shares of Veradigm during the 4th quarter worth $210,000. Finally, Aigen Investment Management LP acquired a new position in shares of Veradigm during the 4th quarter valued at about $231,000.

About Veradigm

(Get Free Report)

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Read More

Analyst Recommendations for Veradigm (NASDAQ:MDRX)

Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.